ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,061.00
+3.00 (0.28%)
Last updated: Aug 6, 2025
0.28%
Market Cap32.68B
Revenue (ttm)61.93B
Net Income (ttm)-10.13B
Shares Out30.98M
EPS (ttm)-327.52
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume9,274
Average Volume446,097
Open1,059.00
Previous Close1,058.00
Day's Range1,055.00 - 1,068.00
52-Week Range797.00 - 1,610.00
Beta0.57
RSI46.03
Earnings DateAug 14, 2025

About The Aaron's Company

ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea. The company produces approximately 200 medicines and health foods, including 30 internal ampoule products, such as Hepos, Fematin, Vasoclean, Mabis, etc. Its products include drugs for digestive, circulatory, and respiratory systems; vitamins, minerals, and nutrients; anti inflammation and analgesics; peripheral nervous system; gynecologic diseases; antibiotics, antigens, and anthelmintic; and antitumor, as well as other metabolite medicines. The company offers i... [Read more]

Industry Pharmaceutical Preparations
Founded 1964
Employees 250
Stock Exchange KOSDAQ
Ticker Symbol 034940
Full Company Profile

Financial Performance

In 2024, KOSDAQ:034940's revenue was 62.69 billion, a decrease of -0.44% compared to the previous year's 62.97 billion. Losses were -9.60 billion, -8.65% less than in 2023.

Financial numbers in CAD Financial Statements

News

There is no news available yet.